These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 22547134)

  • 1. Wiskott-Aldrich syndrome with IgA nephropathy: a case report and literature review.
    Liu CH; Wu KH; Lin TY; Wei CC; Lin CY; Chen XX; Lee WI
    Int Urol Nephrol; 2013 Oct; 45(5):1495-500. PubMed ID: 22547134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IgA glomerulonephritis in Wiskott-Aldrich syndrome.
    DeSanto NG; Sessa A; Capodicasa G; Meroni M; Capasso G; Esposito L; Ferrara M; Torri Tarelli L; Annunziata S; Giordano C
    Child Nephrol Urol; 1988-1989; 9(1-2):118-20. PubMed ID: 3251617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Henoch-Schönlein purpura with immunoglobulin A nephropathy and abnormalities of immunoglobulin A in a Wiskott-Aldrich syndrome carrier.
    Lasseur C; Allen AC; Deminière C; Aparicio M; Feehally J; Combe C
    Am J Kidney Dis; 1997 Feb; 29(2):285-7. PubMed ID: 9016903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IgA nephropathy in a patient with polycythemia vera. Clinical manifestation of chronic renal failure and heavy proteinuria.
    Chung J; Park PG; Song KI
    Am J Nephrol; 2002; 22(4):397-401. PubMed ID: 12169877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary spherocytosis with immunoglobulin A nephropathy.
    Biyikli NK; Gokce I; Cakalagaoglu F; Turkkan E; Alpay H
    Iran J Kidney Dis; 2010 Jan; 4(1):78-81. PubMed ID: 20081310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C; Del Vecchio L; Locatelli F
    G Ital Nefrol; 2002; 19(5):523-8. PubMed ID: 12439840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment and outcome of IgA nephropathy in children from one single center experience.
    Mao Y; Zhou W; Zhou Z; Zhang C; Shen J; Yin L
    BMC Pediatr; 2023 Jul; 23(1):377. PubMed ID: 37495962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of crescentic IgA nephropathy after renal transplantation.
    Zagkotsis G; Vourlakou C; Paraskevopoulos A; Apostolou T
    CEN Case Rep; 2018 Nov; 7(2):268-273. PubMed ID: 29802527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Membranous nephropathy in a female patient with X-linked thrombocytopenia.
    Okada M; Nagasawa M; Oshiba A; Kawaguchi H
    Pediatr Nephrol; 2023 Aug; 38(8):2873-2876. PubMed ID: 36451038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.
    Yagi K; Okada M; Yanagida H; Kuwajima H; Ikeda M; Sugimoto K; Takemura T
    Clin Exp Nephrol; 2003 Dec; 7(4):270-4. PubMed ID: 14712355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antiproteinuric effect of angiotensin antagonism in human IgA nephropathy is potentiated by indomethacin.
    Perico N; Remuzzi A; Sangalli F; Azzollini N; Mister M; Ruggenenti P; Remuzzi G
    J Am Soc Nephrol; 1998 Dec; 9(12):2308-17. PubMed ID: 9848785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful Long-term Graft Survival of a Renal Transplantation Patient with Wiskott-Aldrich Syndrome.
    Kai K; Sumida M; Motoyoshi Y; Ogawa Y; Miki K; Iwadoh K; Sannomiya A; Murakami T; Koyama I; Kitajima K; Nakajima I; Morio T; Fuchinoue S
    Intern Med; 2016; 55(13):1761-3. PubMed ID: 27374679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [IgA nephropathy].
    Alamartine E
    Rev Prat; 2003 Nov; 53(18):2023-6. PubMed ID: 15008216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
    Tanaka H; Suzuki K; Nakahata T; Tsugawa K; Konno Y; Tsuruga K; Ito E; Waga S
    Pediatr Int; 2004 Oct; 46(5):576-9. PubMed ID: 15491387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial.
    Praga M; Gutiérrez E; González E; Morales E; Hernández E
    J Am Soc Nephrol; 2003 Jun; 14(6):1578-83. PubMed ID: 12761258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients
.
    Yang N; Wang X; Xu F; Zeng C; Wang J; Liu Z
    Clin Nephrol; 2017 Apr; 87 (2017)(4):188-195. PubMed ID: 28157068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coexisting Membranous Nephropathy and IgA Nephropathy.
    Nishida M; Kato R; Hamaoka K
    Fetal Pediatr Pathol; 2015; 34(6):351-4. PubMed ID: 26418809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful renal transplantation in a patient with a Wiskott-Aldrich syndrome protein (WASP) gene mutation.
    Chovancova Z; Kuman M; Vlkova M; Litzman J
    Transpl Int; 2015 Aug; 28(8):1005-9. PubMed ID: 25864580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose sirolimus combined with angiotensin-converting enzyme inhibitor and statin stabilizes renal function and reduces glomerular proliferation in poor prognosis IgA nephropathy.
    Cruzado JM; Poveda R; Ibernón M; Díaz M; Fulladosa X; Carrera M; Torras J; Bestard O; Navarro I; Ballarín J; Romero R; Grinyó JM
    Nephrol Dial Transplant; 2011 Nov; 26(11):3596-602. PubMed ID: 21393611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tacrolimus improves the proteinuria remission in patients with refractory IgA nephropathy.
    Zhang Q; Shi SF; Zhu L; Lv JC; Liu LJ; Chen YQ; Zhang H; Wang HY
    Am J Nephrol; 2012; 35(4):312-20. PubMed ID: 22456060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.